Zaburzenie somatyczne
Epidemiologia

Zaburzenie somatyczne (SSD) dotyka około 5-7% populacji ogólnej, z wyższym rozpowszechnieniem w podstawowej opiece zdrowotnej sięgającym około 17%, a w niektórych badaniach nawet do 30,1% (95% CI: 28,13-32,15). Występuje znacznie częściej u kobiet niż u mężczyzn (stosunek 10:1) i może pojawić się w każdym wieku, często przed 30. rokiem życia. SSD współwystępuje z zaburzeniami nastroju i lękowymi u około 57,7% pacjentów, co zwiększa złożoność kliniczną. Wysokie rozpowszechnienie obserwuje się także w grupach z zaburzeniami funkcjonalnymi (25-60%) oraz w ośrodkach zdrowia psychicznego (40,3-77,7%). Zaburzenie to generuje znaczne obciążenie ekonomiczne, z kosztami sięgającymi 22 mld euro rocznie w Europie oraz 256 mld dolarów rocznie w USA, co podkreśla jego istotność w systemach opieki zdrowotnej.

Epidemiologia zaburzenia somatycznego

Zaburzenie somatyczne (ang. Somatic symptom disorder, SSD) stanowi istotny problem w systemach opieki zdrowotnej na całym świecie. Epidemiologia tego zaburzenia jest złożona, a dane dotyczące rozpowszechnienia mogą się różnić w zależności od badanej populacji, zastosowanych kryteriów diagnostycznych oraz metod badawczych.12

Rozpowszechnienie w populacji ogólnej

Szacuje się, że rozpowszechnienie zaburzenia somatycznego w populacji ogólnej wynosi około 5-7%.123 Jednak niektóre badania oparte na kwestionariuszach samooceny wskazują na wyższe rozpowszechnienie, sięgające nawet 12,9% (95% CI: 12,5-13,3%).45 Pojedyncze doniesienia wskazują na jeszcze wyższe wskaźniki, chociaż metodologia tych badań może wpływać na zawyżenie wyników. Niemieckie badanie z 2022 roku przeprowadzone w podstawowej opiece zdrowotnej oszacowało częstość występowania zaburzenia somatycznego na poziomie 7,7%.67

Warto podkreślić, że rozpowszechnienie zaburzenia somatycznego jest znacznie wyższe niż wcześniej diagnozowanego, bardziej restrykcyjnego zaburzenia somatyzacyjnego, którego częstość w próbach z populacji ogólnej szacowano na zaledwie 0,1%.2 Jednocześnie jest ono niższe niż rozpowszechnienie niezróżnicowanego zaburzenia somatoformicznego, które według różnych źródeł mogło dotyczyć nawet 19% populacji.89

Rozpowszechnienie w podstawowej opiece zdrowotnej

W populacji pacjentów podstawowej opieki zdrowotnej rozpowszechnienie zaburzenia somatycznego jest znacznie wyższe i wynosi około 17%.110 Dane z badania przeprowadzonego w Omanie wskazują na jeszcze wyższe wskaźniki – 30,1% (95% CI: 28,13-32,15).1112 Tak wysokie rozpowszechnienie czyni to zaburzenie jednym z najczęstszych problemów, z jakimi spotykają się lekarze podstawowej opieki zdrowotnej.3

W badaniu przeprowadzonym wśród lekarzy podstawowej opieki zdrowotnej w Niemczech, lekarze ocenili, że objawy kliniczne zaburzenia somatycznego (kryteria A i B) występują u 21,5% (95% CI: 20,6-22,3) ich pacjentów.6 Jednocześnie dane kanadyjskie wskazują, że roczne rozpowszechnienie zaburzeń somatoformicznych w podstawowej opiece zdrowotnej może sięgać nawet 25%.13

Warto odnotować, że somatyzacja występuje u nawet 29% pacjentów zgłaszających się do placówek podstawowej opieki zdrowotnej.14 Ponadto, szacuje się, że 20-60% wizyt ambulatoryjnych stanowią przypadki z medycznie niewyjaśnionymi objawami.15

Rozpowszechnienie w populacjach specjalnych

U pacjentów z rozpoznanymi zaburzeniami funkcjonalnymi, takimi jak fibromialgia, zespół jelita drażliwego czy zespół przewlekłego zmęczenia, rozpowszechnienie zaburzenia somatycznego jest istotnie wyższe.1 Szacuje się, że w tych grupach pacjentów częstość występowania zaburzenia somatycznego może wynosić od 25% do nawet 60%.1617

Badania wskazują również na wysokie rozpowszechnienie zaburzenia somatycznego u pacjentów z zawrotami głowy lub objawami zawrotu głowy.18 W specjalistycznych ośrodkach zdrowia psychicznego zajmujących się leczeniem zaburzenia somatycznego częstość występowania tego zaburzenia jest najwyższa i waha się między 40,3% a 77,7% (średnia częstość 60,1%, 95% CI: 57,8-62,4%).4

Badanie przeprowadzone wśród pacjentów psychiatrycznych w wieku młodzieńczym wykazało, że aż 93,8% zgłaszało objawy somatyczne w ciągu ostatnich sześciu miesięcy, a 45,7% zgłaszało co najmniej jeden objaw somatyczny w ciągu ostatnich siedmiu dni przed badaniem. W odniesieniu do ostatnich sześciu miesięcy, 59,5% pacjentów spełniało kryteria przesiewowe zaburzeń somatoformicznych.1920

Rozpowszechnienie z uwzględnieniem płci i wieku

Zaburzenie somatyczne występuje znacznie częściej u kobiet niż u mężczyzn, ze stosunkiem częstości występowania szacowanym na 10:1.32122 Może to być częściowo związane z większą gotowością kobiet do zgłaszania objawów somatycznych.21 W ogólnej populacji oczekiwane rozpowszechnienie wynosi około 2% wśród kobiet i 0,2% wśród mężczyzn.14

Zaburzenie somatyczne może wystąpić w dzieciństwie, okresie dojrzewania lub wczesnej dorosłości.13 Dane wskazują, że objawy prodromalne często pojawiają się w dzieciństwie, a objawy spełniające kryteria zaburzenia somatycznego są powszechne w okresie dojrzewania. Badanie społeczności nastolatków wykazało, że 5% miało uporczywe, niepokojące objawy fizyczne połączone z problemami psychologicznymi.16

Szacuje się, że 25% populacji poniżej 18. roku życia zgłasza jeden lub więcej objawów somatycznych tygodniowo. Około 10% dzieci odwiedzających pediatrę z jakiegokolwiek powodu ma objawy fizyczne, których nie można przypisać żadnej rozpoznawalnej chorobie, ale które mają znaczący wpływ na ich codzienne życie.23

Interesujące jest, że dostępne dane sugerują, iż wskaźniki rozpowszechnienia mogą zmniejszać się po 65. roku życia.2 Jednak chińskie badanie z 2022 roku wykazało, że rozpowszechnienie zaburzenia somatycznego u osób starszych było wyższe niż u osób młodszych (63,2% vs 45,3%), a osoby starsze cierpiały na cięższe postaci zaburzenia (20,4% umiarkowane i ciężkie u osób starszych vs 12,0% u osób młodszych).24

Czynniki ryzyka i współwystępowanie

Badania zidentyfikowały kilka czynników ryzyka rozwoju zaburzenia somatycznego, w tym:

  • Płeć żeńska321
  • Niższy status społeczno-ekonomiczny2526
  • Niższy poziom wykształcenia2726
  • Przynależność do mniejszości etnicznych2726
  • Zaniedbanie w dzieciństwie, wykorzystywanie seksualne328
  • Chaotyczny styl życia3
  • Historia nadużywania alkoholu i substancji psychoaktywnych3
  • Współwystępujące choroby somatyczne2429

Zaburzenie somatyczne często współwystępuje z innymi zaburzeniami psychicznymi, szczególnie z zaburzeniami nastroju i zaburzeniami lękowymi.27 Chorobowość współistniejących zaburzeń depresyjnych lub lękowych jest 3,7 razy wyższa niż można by oczekiwać w populacji ogólnej.24 DSM-5 stwierdza, że zaburzenie somatyczne współwystępujące z zaburzeniami lękowymi i depresyjnymi (połączenie obecne u około 57,7% pacjentów z zaburzeniem somatycznym) zwiększa ciężkość i złożoność komponentów somatycznych.30

Badania wykazały również współwystępowanie zaburzenia somatycznego z zaburzeniami osobowości, szczególnie z antyspołecznym, borderline, narcystycznym, histrionicznym, unikającym i zależnym zaburzeniem osobowości.27 Około 10-20% krewnych pierwszego stopnia płci żeńskiej również ma zaburzenie somatyczne, a krewni płci męskiej mają zwiększone wskaźniki alkoholizmu i socjopatii.27

Obciążenie systemów opieki zdrowotnej

Zaburzenie somatyczne stanowi znaczące obciążenie ekonomiczne dla systemów opieki zdrowotnej. Europejskie badanie oszacowało koszt zaburzeń somatycznych w Europie na 22 miliardy euro rocznie (około 30 miliardów dolarów amerykańskich rocznie). Stawia to koszt zaburzeń somatycznych w zakresie porównywalnym z kosztami leczenia stwardnienia rozsianego, choroby Parkinsona lub urazowego uszkodzenia mózgu.18

W Ontario w Kanadzie, ponad 33 000 dzieci, młodzieży i młodych dorosłych (do 24. roku życia) zostało zidentyfikowanych w dokumentacji medycznej jako cierpiących na zaburzenia somatyczne w ciągu 7-letniego okresu. W przypadku dzieci i młodzieży hospitalizowanych z powodu zaburzenia somatycznego, średnie koszty systemu opieki zdrowotnej wynosiły łącznie 52 621 CAD w roku przed i po diagnozie, co jest porównywalne z kosztami opieki nad niektórymi najbardziej medycznie złożonymi przypadkami dzieci.31

Roczny koszt opieki medycznej wśród pacjentów z somatyzacją jest prawie dwa razy wyższy niż roczny koszt wśród pacjentów bez somatyzacji. Szacuje się, że 256 miliardów dolarów w rocznych kosztach opieki medycznej w USA można przypisać przyrostowym efektom samej somatyzacji.32

Wyzwania związane z nadzorem i diagnostyką

Epidemiologia zaburzenia somatycznego napotyka na szereg wyzwań związanych z nadzorem i diagnostyką. Jako że zaburzenie somatyczne zostało wprowadzone do DSM-5 dopiero w 2013 roku, badania dotyczące jego rozpowszechnienia są wciąż ograniczone.3334

Aktualny brak badań badających rozpowszechnienie zaburzenia somatycznego w oparciu o standardowe wywiady kryterialnego stanowi istotną lukę badawczą, uniemożliwiającą wiarygodne oszacowanie rozpowszechnienia tego zaburzenia.4 Tylko siedem badań wykorzystało częściowo ustrukturyzowane wywiady kliniczne oparte na kryteriach DSM-5 do diagnozy zaburzenia somatycznego.4

Ponadto, wymaganie wykluczenia przyczyn somatycznych jest konieczne do diagnozowania zaburzeń somatoformicznych, co powoduje, że istnieje niewiele informacji na temat rozpowszechnienia takich zaburzeń w społeczności.35 Mimo to, są dostępne różne narzędzia przesiewowe, które mogą pomóc w identyfikacji pacjentów zagrożonych zaburzeniem somatycznym.36 Wykorzystanie takich narzędzi jak PHQ-15, WI-7 i SAIB w rutynowej opiece może prowadzić do poprawy wskaźników wykrywalności.37

Różnice kulturowe i geograficzne

Istnieją różnice kulturowe w rozpowszechnieniu zaburzenia somatycznego. Na przykład, zaburzenie somatyczne i jego objawy są znacznie częstsze w Portoryko.27 Ponadto, diagnoza ta jest również bardziej rozpowszechniona wśród Afroamerykanów.27

Typ i częstość skarg somatycznych mogą różnić się między kulturami, dlatego przeglądy objawów powinny być dostosowane w oparciu o kulturę. Zaburzenia somatyczne są częstsze w kulturach bez zachodnich/empirycznych modeli wyjaśniających.14

Badanie przeprowadzone w Belgii wykazało, że zespół somatyzacji jest trzecim najczęstszym zaburzeniem psychiatrycznym, z wskaźnikiem rozpowszechnienia wynoszącym 8,9%. Pierwszymi i drugimi najczęstszymi zaburzeniami psychiatrycznymi są depresja i zaburzenia lękowe.18

Zaburzenie somatyczne w kontekście populacji dziecięcej i młodzieżowej

Zaburzenia somatoformiczne (SD), rozpoczynające się w okresie dojrzewania, stanowią poważny problem w systemach opieki zdrowotnej.19 Objawy somatyczne wpływają na około 25% dzieci i młodzieży, przy znaczącym wpływie u 10%, a zaburzenia somatyzacyjne dotykają 1-3% populacji.3823

Chociaż literatura podkreśla wysoką obecność problemów ze zdrowiem psychicznym wśród dzieci i młodzieży dotkniętych objawami somatycznymi w populacji ogólnej, dostępne są ograniczone dowody na temat rozpowszechnienia współistniejących objawów somatycznych w populacjach psychiatrycznych dzieci i młodzieży.19

Badania dostarczają dowodów, że objawy somatyczne są częste u dzieci i młodzieży leczonych w psychiatrii dziecięcej i młodzieżowej oraz są istotne dla codziennego funkcjonowania.20 Zaburzenia somatyczne wpływają na jakość życia pacjentów, adaptację rodzinną i społeczną, rozwój poznawczy, wyniki w nauce i nastrój.38

Implikacje dla praktyki klinicznej i badań

Dane epidemiologiczne dotyczące zaburzenia somatycznego mają szereg implikacji dla praktyki klinicznej i przyszłych badań:

  • Badania przesiewowe w kierunku objawów somatycznych powinny być wprowadzone w rutynowych procedurach diagnostycznych w celu wczesnego wykrywania zaburzeń somatycznych w początkowych stadiach.20
  • Szczególną uwagę należy zwrócić na badania przesiewowe w kierunku zaburzenia somatycznego u osób starszych, zwłaszcza wśród starszych kobiet z kilkoma współistniejącymi chorobami fizycznymi.39
  • Istnieje potrzeba przeprowadzenia dalszych intensywnych badań z wykorzystaniem prób opartych na populacji oraz pacjentów zgłaszających się na konsultacje do ośrodków podstawowej opieki zdrowotnej.40
  • Sugeruje się stosowanie kwestionariusza PHQ-15 w praktyce klinicznej, szczególnie w placówkach podstawowej opieki zdrowotnej, jako skutecznego narzędzia przesiewowego.15
  • Dane sugerują, że objawy somatyczne u pacjentów psychiatrycznych dzieci i młodzieży są tak częste, że – począwszy od 11. roku życia, a zwłaszcza u pacjentów z objawami internalizacji – badania przesiewowe w kierunku objawów somatycznych i zaburzeń somatycznych powinny być zintegrowane z rutynowymi procedurami diagnostycznymi.41

Niezbędne są dalsze badania w celu lepszego zrozumienia epidemiologii zaburzenia somatycznego, szczególnie w kontekście różnych kultur, grup wiekowych i płci. Ponadto, potrzebne są badania dotyczące zastosowania narzędzi diagnostycznych u pacjentów zarówno z zaburzeniem somatycznym, jak i zdiagnozowanymi zaburzeniami medycznymi.30

Podsumowanie danych epidemiologicznych

Zaburzenie somatyczne jest stosunkowo powszechnym zaburzeniem psychicznym, dotykającym około 5-7% populacji ogólnej i około 17% pacjentów podstawowej opieki zdrowotnej. Jest ono znacznie częstsze u kobiet niż u mężczyzn, ze stosunkiem częstości występowania szacowanym na 10:1. Może wystąpić w każdym wieku, chociaż często rozpoczyna się przed 30. rokiem życia.

Zaburzenie to ma istotny wpływ na systemy opieki zdrowotnej, przyczyniając się do znacznych kosztów ekonomicznych. Współwystępuje często z innymi zaburzeniami psychicznymi, zwłaszcza z zaburzeniami nastroju i zaburzeniami lękowymi, co może dodatkowo komplikować diagnozę i leczenie.

Wymagane są dalsze badania w celu lepszego zrozumienia epidemiologii zaburzenia somatycznego, szczególnie z wykorzystaniem standardowych wywiadów kryterialnych w różnych populacjach i kulturach. Lepsze zrozumienie epidemiologii może przyczynić się do poprawy wykrywania, diagnozy i leczenia tego istotnego klinicznie zaburzenia.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Somatic Symptom Disorder – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK532253/
    The prevalence of somatic symptom disorder (SSD) is estimated to be 5% to 7% of the general population, with higher female representation (female-to-male ratio 10:1), and can occur in childhood, adolescence, or adulthood. […] The prevalence increases to approximately 17% of the primary care patient population. […] The prevalence is likely higher in certain patient populations with functional disorders, including fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome.
  • #2 Somatic Symptom Disorders: Background, Pathophysiology, Epidemiology
    http://emedicine.medscape.com/article/914594?mobile-app=true&theme=wiki
    Prevalence rates for the most restrictive previous diagnosis of somatization disorder appear low in community samples (0.1%). Low community prevalence rates for somatic symptom disorder may be due to a reporting bias. […] One review estimates that the prevalence of somatic symptom disorder in the general population is approximately 5%7%. This suggests that these concerns are among the most common patient concerns in the primary care setting. […] An estimated 20%25% of patients who present with acute somatic symptoms go on to develop a chronic somatic illness. These disorders can begin in childhood, adolescence, or adulthood. […] The existing evidence shows that somatoform disorders and medically unexplained symptoms are common in later life. The available data suggest that prevalence rates may decline after the age of 65 years.
  • #3 Somatic Symptom Disorder | AAFP
    https://www.aafp.org/pubs/afp/issues/2016/0101/p49.html
    The prevalence of somatic symptom disorder in the general population is an estimated 5% to 7%, making this one of the most common categories of patient concerns in the primary care setting. An estimated 20% to 25% of patients who present with acute somatic symptoms go on to develop a chronic somatic illness. These disorders can begin in childhood, adolescence, or adulthood. Females tend to present with somatic symptom disorder more often than males, with an estimated female-to-male ratio of 10:1. […] Somatic symptoms may result from a heightened awareness of certain bodily sensations, combined with a tendency to interpret these sensations as indicative of a medical illness. The etiology of somatic symptom disorder is unclear. However, studies have determined that risk factors for chronic and severe somatic symptoms include childhood neglect, sexual abuse, chaotic lifestyle, and a history of alcohol and substance abuse. In addition, somatic symptom disorder has been associated with personality disorders.
  • #4 Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis | Psychological Medicine | Cambridge Core
    https://www.cambridge.org/core/journals/psychological-medicine/article/somatic-symptom-disorder-a-scoping-review-on-the-empirical-evidence-of-a-new-diagnosis/25B7921C514E9B42280B6A7376289729
    In 2013, the diagnosis of somatic symptom disorder (SSD) was introduced into the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). […] General population studies using self-report questionnaires reported mean frequencies for SSD of 12.9% [95% confidence interval (CI) 12.5-13.3%], while prevalence studies based on criterion standard interviews are lacking. […] The current lack of studies examining the prevalence of SSD based on criterion-standard interviews is a major research gap, precluding reliable estimates of the prevalence of SSD. […] Only seven studies used semi-structured clinical interviews based on DSM-5 criteria to diagnose SSD. […] Prevalence studies in the general population using diagnostic criterion standard interviews are completely missing. […] SSD frequency rates in different medical and non-medical populations are summarized in Fig. 2. In general population studies, the frequency of proxy diagnosis for SSD varied between 6.7 and 17.4% [mean frequency 12.9% (95% confidence interval (CI) 12.5-13.3%)]. […] The highest frequency of SSD was observed within mental health care settings specialized in SSD treatment with frequency rates ranging between 40.3 and 77.7% [mean frequency 60.1% (95% CI 57.8-62.4%)].
  • #5 Somatic Symptom Disorder | PM&R KnowledgeNow
    https://now.aapmr.org/somatic-symptom-disorder/
    Historically, the prevalence of SSD was difficult to establish as the diagnostic criteria under the DSM-V subsumed other somatoform disorders such as hypochondriasis and panic disorder. An article by Kurlansik and Maffei estimates the prevalence of SSD as between 5 and 7% in the general population and 17% in the primary care population. Onset of SSD can begin in adolescence or childhood, and is considered more common in females than in males, with female to male ratios being estimated at 10:1. Further studies examined the incidence of SSD in the general population via self-report questionnaires and found that mean frequencies of SSD in the population were as high as 12.9% (CI 12.5-13.3 95%). When compared to previous somatic symptom disorders (i.e., somatization disorder, undifferentiated somatoform disorder, pain disorder, etc.) SSD was found to exhibit both reliability and validity, as well as good clinical utility.
  • #6 Estimated frequency of somatic symptom disorder in general practice: cross-sectional survey with general practitioners | BMC Psychiatry | Full Text
    https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-022-04100-0
    Somatic symptom disorder (SSD) is the successor diagnosis of somatoform disorder in the 5th Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Relevance and frequency of SSD and its clinical symptoms in general practice are still unknown. We estimate frequencies of patients fulfilling the diagnostic criteria of SSD in general practice. […] GPs saw the clinical symptoms of SSD fulfilled (A and B criteria) in 21.5% (95% CI: 20.6 to 22.3) of their patients. […] We estimate a frequency of 7.7% of patients in general practice to fulfil the diagnostic criteria of SSD. This number may figure as a reference for the yet to be uncovered prevalence of SSD and it indicates a high clinical relevance of the clinical symptoms of SSD in general practice. […] Representative and unbiased prevalence studies for SSD are still rare as evidenced in a recent scoping review.
  • #7 Somatic Symptom Disorder: Causes and Symptoms
    https://patient.info/doctor/somatic-symptom-disorder
    How common is somatic symptom disorder? (Epidemiology) […] A German 2022 study reported a prevalence of 7.7% for somatic symptom disorder (SSD) in primary care. […] A large scale, 2022 community-based study in China reported that SSD was more prevalent in people over 60 years of age. […] Epidemiological studies generally quote a prevalence of 5-7% for the general population. […] The disorder usually begins before the age of 30 years and occurs more often in women than in men.
  • #8 Somatic Symptom Disorder – PsychDB
    https://www.psychdb.com/somatic/dsm-5/somatic-symptom
    The prevalence of somatic symptom disorder is unknown since it is a new diagnosis, but estimated to be between 5 to 7%. […] The prevalence is expected to be higher than the older and more restrictive DSM-IV diagnosis of somatization disorder (1%) but lower than that of undifferentiated somatoform disorder (19%). […] It affects females more than males.
  • #9 DSM 5 Somatic Symptom and Related Disorders | Working Fit
    http://www.workingfit.co.uk/medical-evidence/unexplained-and-exaggerated-symptoms/dsm-5-somatic-symptom-and-related-disorders
    The expected prevalence of Somatic Symptom Disorder stated in DSM 5 is higher than that for Somatization Disorder (<1%) but lower than that of Undifferentiated Somatoform Disorder (19%). Both are more common in women. Nevertheless, the term Somatic Symptom Disorder is considered by DSM 5 to be broadly equivalent to ICD10 F45.1 and ICD9 300.82 Undifferentiated Somatoform Disorder, and includes most patients with Hypochondriasis ICD 10 F45.21 and ICD 9 300.7. [...] DSM 5 considers the prevalence to be around 5% of referrals to neurology clinics, with an annual incidence in the general population of 2-5/100,000. [...] While the prevalence is not clear, DSM 5 notes that it is more common than Somatic Symptom Disorder.
  • #10 Azthena logo with the word Azthena
    https://www.news-medical.net/health/What-is-Somatic-Symptom-Disorder.aspx
    The epidemiology of somatic symptom disorder is not reliable. However, reasonable assumption dictates that the rate of patients with somatic symptom disorder is greater in the population as well as in the primary, specialist, and mental healthcare realms relative to the rates for more narrowly defined multi-symptomatic somatoform subcategorizations. […] Despite this, the prevalence of somatic symptom disorder has been estimated to be between 5% and 7% of the general population, occurring with a higher rate in females, at a female to male ratio of 10:1. Somatic symptom disorder may occur in childhood, adolescence, or adulthood. When patient populations are further subcategorized, those who have functional disorders, such as fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome, exhibit higher prevalence rates. Moreover, prevalence rises to ~ 17% of the primary care population.
  • #11 Epidemiology and prevalence of somatic symptom disorder at the primary care level in Muscat, Oman: A cross-sectional study – PubMed
    https://pubmed.ncbi.nlm.nih.gov/35430921/
    Objectives: Somatic symptom disorder (SSD) is a diagnostic classification to describe the occurrence of physical symptoms without organic cause. This study aimed to identify prevalence rates and associated characteristics of SSD among adults in primary care settings. […] A total of 2000 adults participated in the study (response rate: 67.3%), of which most were female (71.7%) and under 50 years old (86.2%). Based on their SSS-8 scores, 602 participants (17.8%) had SSD, resulting in an overall prevalence estimate of 30.1% (95% confidence interval: 28.13-32.15). […] The estimated prevalence of SSD in primary care settings is high compared to reports from elsewhere in the Gulf region. There is an urgent need to enhance the diagnosis of SSD at the primary care level in order to reduce healthcare service overutilisation and patient dissatisfaction.
  • #12 Epidemiology and prevalence of somatic symptom disorder at the primary care level in Muscat, Oman: A cross-sectional study. | EBSCOhost
    https://search.ebscohost.com/login.aspx?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=00912174&AN=163264303&h=R85HEmkHxjYiLtAl%2BcIQXjUR%2BrxVsZPgJbcXxMHOzdgZR6%2FOh2IryTHzZK1v1wyQomEpLWZ2jXN%2BlAE4vimIag%3D%3D&crl=f
    Epidemiology and prevalence of somatic symptom disorder at the primary care level in Muscat, Oman: A cross-sectional study. […] This study aimed to identify prevalence rates and associated characteristics of SSD among adults in primary care settings. […] A total of 2000 adults participated in the study (response rate: 67.3%), of which most were female (71.7%) and under 50 years old (86.2%). Based on their SSS-8 scores, 602 participants (17.8%) had SSD, resulting in an overall prevalence estimate of 30.1% (95% confidence interval: 28.13–32.15). […] The estimated prevalence of SSD in primary care settings is high compared to reports from elsewhere in the Gulf region.
  • #13 Somatization: Supporting the Patient with Somatization in Primary Care : Ottawa-Carleton, ON : eMentalHealth.ca
    https://primarycare.ementalhealth.ca/index.php?m=fpArticle&ID=26040
    1-year prevalence of somatoform disorders is almost 25% in primary care (Steinbrecher et al., 2011) […] Patients with chronic medically unexplained symptoms, of whom the majority have somatization, are extremely common in primary care.
  • #14 Somatic Symptom (Somatization) Disorder | 5-Minute Clinical Consult
    https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/1688015/all/Somatic_Symptom__Somatization__Disorder?q=Stress+disorder
    Usually, first symptoms appear in adolescence. […] Predominant sex: female male (10:1) […] Type and frequency of somatic complaints may differ among cultures, so symptom reviews should be adjusted based on culture; more frequent in cultures without Western/empirical explanatory models. […] Expected 2% among women and 0.2% among men. […] Somatization is seen in up to 29% of patients presenting to primary care offices. […] Somatic concerns may increase, but other features of the presentation decrease such that prevalence declines after age 65 years.
  • #15 Exploring Somatic Symptom Disorder: A Case Report
    https://www.psychiatrictimes.com/view/exploring-somatic-symptom-disorder-a-case-report
    Often underdiagnosed, somatic symptom disorder affects individuals of all ages with and without concomitant psychiatric disorders. […] They reported prevalence of somatic symptom disorder tends to decrease after age 65 years, with rates range from 11% to 21% in younger patients, 10% to 20% in middle-aged patients, and 1.5% to 13% in older patients. […] Ali said in the poster presentation. She added, We know that primary care physicians, psychiatrists, and neurologists encounter most of the cases, where 20% to 60% of outpatient visits constitute of medically unexplained symptoms. […] The concept of mind-body dualism might pose a challenge in early identification of the condition and subsequently lead to frequent hospital visits, numerous diagnostic tests, and an overall increase in health care costs and patient dissatisfaction, Ali reported. […] She also suggested the use of PHQ-15 in clinical practice, especially in primary care settings, as an effective screening tool.
  • #16 Somatic symptom disorder – Wikipedia
    https://en.wikipedia.org/wiki/Somatic_symptom_disorder
    Somatic symptom disorder affects 5% to 7% of the general population, with a higher female representation, and can arise throughout childhood, adolescence, or adulthood. […] A 2015 study found prevalence of 11% (n = 5738). […] Evidence suggests that the emergence of prodromal symptoms often begins in childhood and that symptoms fitting the criteria for somatic symptom disorder are common during adolescence. A community study of adolescents found that 5% had persistent distressing physical symptoms paired with psychological concerns. […] In the primary care patient population, the rate rises to around 17%. […] Patients with functional illnesses such as fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome have a greater prevalence of somatic symptom disorder. The reported frequency of somatic symptom disorder, as defined by the DSM-5 criteria, ranges from 25 to 60% among these patients.
  • #17 Somatic Symptom Disorder | PM&R KnowledgeNow
    https://now.aapmr.org/somatic-symptom-disorder/
    Extrapolating data from the prior diagnoses that contribute to SSD to determine prevalence was considered but rejected because not all patients with the former diagnoses would qualify for the SSD diagnoses under the DSM-V, particularly in those with unexplained symptoms. Also, there are additional patients with explained medical conditions that can now be diagnosed with SSD if they suffer from the B and C criteria. This leads to concern for the risk of those with known medical disease having their symptoms attributed to psychological distress if they also qualify for the SSD diagnosis. With suspected prevalence rates of SSD at up to 25 to 60% in patients with functional somatic syndromes (i.e., fibromyalgia, chronic fatigue syndrome irritable bowel syndrome) it is important to avoid ascribing all somatic symptoms to SSD despite any overlap.
  • #18 Somatic Symptom Disorders: Background, Pathophysiology, Epidemiology
    http://emedicine.medscape.com/article/914594?mobile-app=true&theme=wiki
    There is evidence that somatic symptom disorder is highly prevalent in patients suffering from vertigo or dizziness symptoms. […] A study in Belgium reported that somatization syndrome is the third highest psychiatric disorder, with a prevalence rate of 8.9%. The first and second most common psychiatric disorders were depression and anxiety disorders. […] Somatic symptom disorders contribute a significant economic burden to the costs of brain disorders. A European survey estimated the cost of somatic symptom disorders across Europe to be 22 billion Euro/year (approximately $30 billion US dollars per year). This makes the cost of somatic symptom disorders in the range of that for multiple sclerosis, Parkinson disease, or traumatic brain injury. […] Somatic symptom disorders do not appear to independently increase the risk of death. Some evidence exists that somatization disorder is associated with increased risk for suicide attempts.
  • #19 Prevalence of Somatic Symptoms and Somatoform Disorders among a German Adolescent Psychiatric Inpatient Sample
    https://www.mdpi.com/2227-9067/11/3/280
    Somatoform disorders (SD), commencing during adolescence, represent a major problem in health care systems. […] While literature underlines the high presence of mental health problems among children and adolescents afflicted by somatic symptoms in the general population, limited evidence is available on the prevalence of comorbid somatic symptoms in child and adolescent psychiatric populations. […] A total of 93.8% of the inpatients reported somatic symptoms within the past six months and still almost half (45.7%) of the sample reported at least one somatic symptom within the last seven days prior to inquiry. […] Relating to the past six months, 59.5% were positively screened for SD, and 44.6% reported symptoms eligible for positive screening within the past seven days prior to the survey.
  • #20 Prevalence of Somatic Symptoms and Somatoform Disorders among a German Adolescent Psychiatric Inpatient Sample
    https://www.mdpi.com/2227-9067/11/3/280
    We provide evidence that somatic symptoms are frequent in children and adolescents being treated in child and adolescent psychiatry and are relevant to everyday functioning. […] Screening for somatic symptoms should be introduced in the routine diagnostic procedures for early detection of SD in the commencing stages. […] In general, somatic symptoms account for a significant amount of pediatric outpatient attendances. […] However, only a few studies have focused on somatic symptoms in child and adolescent psychiatric inpatient cohorts who might represent a vulnerable population in the context of somatoform disorders. […] In summary, somatic symptoms are relevant and impairing with respect to everyday functioning. […] Therefore, the prevalence and clinical relevance of somatic symptoms and their interrelations with different diagnostic categories and symptoms of depression and anxiety, but also sex and age, are of particular interest among the highly vulnerable inpatient child and adolescent samples.
  • #21 Somatic Symptom Disorders: Background, Pathophysiology, Epidemiology
    http://emedicine.medscape.com/article/914594?mobile-app=true&theme=wiki
    Previous research indicates that suicidality is a substantial problem in primary care patients with somatoform disorders, especially when major depression or anxiety realm disorders are comorbid. […] Females tend to present with somatic symptom disorder more frequently than males, with an estimated F:M ratio of 10:1. This may be due to a greater willingness to report somatic symptoms in the female population. […] Somatic symptom disorders may begin in childhood, adolescence, or early adulthood. New onset of unexplained somatic symptom disorders in older adults should prompt a search for occult medical illness or evidence of major depression associated with somatization.
  • #22 Somatic Symptom Disorder: What It Is, Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/17976-somatic-symptom-disorder-in-adults
    Somatic symptom disorder can occur in children, adolescents and adults, and it usually begins by age 30. […] Women are 10 times more likely to be diagnosed with somatic symptom disorder. […] Somatic symptom disorder is somewhat common and occurs in about 5% to 7% of the adult population.
  • #23 Somatization in childhood and adolescence: a guide to facilitate its understanding | Anales de Pediatría
    https://analesdepediatria.org/en-somatization-in-childhood-adolescence-guide-articulo-S2341287925000237
    Somatic symptoms affect approximately 25% of children and adolescents, with a significant impact in 10%, and somatization disorders affect 1%3% of the population. […] The estimated prevalence of somatic symptom disorders is approximately one to three percent. […] It is estimated that 25% of the population aged less than 18 years complains of one or more of these symptoms weekly. Of all children who visit the pediatrician for any reason, approximately 10% have physical symptoms that cannot be attributed to any recognizable disease but have a significant impact on their daily life. […] Overall, there is a higher prevalence of these disorders in the female population, and the age at onset is greater in conversion disorder compared to somatic symptom disorder.
  • #24 Prevalence and characteristics of somatic symptom disorder in the elderly in a community-based population: a large-scale cross-sectional study in China | BMC Psychiatry | Full Text
    https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-022-03907-1
    The prevalence of SSD in the elderly was higher than that in the non-elderly (63.2% vs. 45.3%). […] The elderly suffered more severe SSD (20.4% moderate and severe in elderly vs. 12.0% in non-elderly) and are 1.560 times more likely to have the disorder (95%CI: 1.3991.739; p<.001) than the non-elderly. [...] Comorbidity of depressive or anxiety disorders was 3.7 times higher than would be expected in the general population. [...] Additionally, the results of adjusted multivariate analyses identified older age, female sex, and comorbid physical diseases as predictive risk factors of SSD in the elderly group. [...] With higher prevalence of common physical problems (including hypertension, diabetes mellitus and cardio/cerebrovascular disease), the elderly in Shanghai are more vulnerable to have SSD and are more likely to suffer from comorbid depressive and anxiety disorders.
  • #25 Somatic Symptom Disorder | AAFP
    https://www.aafp.org/pubs/afp/issues/2016/0101/p49.html
    Psychosocial stressors and culture affect how patients present to the physician. For example, studies in primary care settings found significantly higher rates of unemployment and impaired occupational functioning in somaticizing patients compared with nonsomaticizing patients (29% vs. 15%, and 55% vs. 14%, respectively).
  • #26
    https://step1.medbullets.com/psychiatry/114037/somatic-symptom-and-related-disorders
    Epidemiology […] F M […] less educated […] lower socioecononimc status […] ethnic minorities […] […] […] Somatic symptom disorder […] one or more physical symptoms that cause distress […] dysfunctional thoughts, feelings, or behaviors associated with the physical symptoms […] dysfunction is present for at least six months […] […] […] pain disorder […] chronic pain that causes significant distress or impairment […] psychological factors appear to influence the experience of the pain […] […] […] conversion disorder […] neurological impairment involving voluntary motor or sensory function with no primary neurological cause […] […] […] more common in adolescents and young adults […] […] […] illness anxiety disorder
  • #27 Somatic symptom disorder – Wikipedia
    https://en.wikipedia.org/wiki/Somatic_symptom_disorder
    There are cultural differences in the prevalence of somatic symptom disorder. For example, somatic symptom disorder and symptoms were found to be significantly more common in Puerto Rico. […] In addition, the diagnosis is also more prevalent among African Americans and those with less than a high school education or lower socioeconomic status. […] There is usually co-morbidity with other psychological disorders, particularly mood disorders or anxiety disorders. […] Research also showed comorbidity between somatic symptom disorder and personality disorders, especially antisocial, borderline, narcissistic, histrionic, avoidant, and dependent personality disorder. […] About 10-20% of female first degree relatives also have somatic symptom disorder and male relatives have increased rates of alcoholism and sociopathy.
  • #28 Somatic Symptom Disorder | PM&R KnowledgeNow
    https://now.aapmr.org/somatic-symptom-disorder/
    Risk factors/primary prevention: Substance use, and childhood sexual abuse and neglect have been identified as potential risk factors for SSD or somatization. There is also published research regarding correlations involving SSD. One study shows that for patients suffering from psychogenic non-epileptic seizures, patients who also qualify for an SSD diagnosis are more likely to report polyallergy. Another study stated that for patients being evaluated for multiple sclerosis, if they brought a list of symptoms, there was a high incidence of SSD. The aforementioned studies suggest a potential behavioral or personality based component that may indicate risk of SSD symptoms. Risk factors that have been historically associated with somatoform disorders and somatization include female sex, fewer years of education, lower socioeconomic status, history of childhood chronic illness, history of sexual abuse or other trauma, and concurrent general medical or psychiatric disorders. It is important to note that this data is based on previous studies of multiple types of somatoform disorders and not on the newer diagnostic criteria for SSD under the DSM-V. It is possible that many of these risk factors also apply to SSD; however, caution should be taken to avoid the mislabeling of women and those who are undereducated or socioeconomically disadvantaged as catastrophizers when presenting with physical symptoms.
  • #29 The epidemiology of multiple somatic symptoms – ePrints Soton
    https://eprints.soton.ac.uk/492273/
    The risk factors for a high total somatic symptom count are unclear; and it is not known whether total somatic symptoms count is a predictor of impaired health status. […] Risk factors for a persistent high SSI were: fewer than 12 years of education, separated, widowed or divorced status, reported psychological abuse during childhood, co-existing medical illnesses, anxiety and depression. […] The risk factors for total somatic symptom count were those associated with psychiatric disorders including physical illness. […] A persistent high somatic symptom count provides a readily measured dimension of importance in epidemiology as a predictor of health status.
  • #30 Identifying and measuring the severity of somatic symptom disorder using the Self-reported Somatic Symptom Scale-China (SSS-CN): a research protocol for a diagnostic study | BMJ Open
    https://bmjopen.bmj.com/content/9/9/e024290
    The DSM-5 states that SSD comorbid with anxiety and depressive disorder (a combination present in approximately 57.7% of patients with SSD) adds severity and complexity to the somatic components. […] The current study, however, represents the efficacy of the SSS-CN only in patients without organic diseases. Therefore, further research on the application of SSS-CN in patients with both SSD and diagnosed medical disorders is required. Moreover, the epidemiology of primary healthcare facilities is different from the epidemiology of general hospitals; therefore, the diagnostic accuracy in a healthcare sample requires additional investigation.
  • #31 Somatic symptom and related disorders: Guidance on assessment and management for paediatric health care providers | Canadian Paediatric Society
    https://cps.ca/documents/position/somatic-symptom-and-related-disorders
    Somatic symptom and related disorders (SSRD) refer to a category of mental disorders that commonly affect children and adolescents. Individuals with SSRDs have high health system utilization. […] Exact prevalence estimates of SSRDs are uncertain due to the non-specific nature of symptoms and the universal experience of somatization that does not cross the disorder threshold. Published estimates from European studies range from 4.1% to 12.6% of children and adolescents who at some point meet criteria for diagnosis. […] In Ontario, over 33,000 children, youth, and young adults (up to 24 years old) were identified in health records to have SSRDs over a 7-year period. […] Individuals with SSRDs have high health system utilization rates (and related costs), school absenteeism, high rates of disability, and variable prognoses. […] For children and youth hospitalized with an SSRD, mean health system costs were a combined $52,621 CAD in the year before and after diagnosis, on a par with some of the most medically complex children.
  • #32 Identifying and measuring the severity of somatic symptom disorder using the Self-reported Somatic Symptom Scale-China (SSS-CN): a research protocol for a diagnostic study | BMJ Open
    https://bmjopen.bmj.com/content/9/9/e024290
    Somatic symptom disorder (SSD) is a common medical condition observed in general hospitals. The current prevalence of this disorder is estimated to be 5%7% in the general population, and it may be even higher in Asian individuals. In general hospitals, the detection rate of SSD is unsatisfactory due to the diagnostic complexity of the disease and the lack of adequate training for physicians to evaluate patients with suspected SSD. […] The yearly cost of medical care among patients with somatisation is nearly twice as high as the yearly cost among patients without somatisation. An estimated $256 billion in annual medical care costs is attributable to the incremental effects of somatisation alone. […] However, compared with widely researched disorders such as depression and anxiety, SSD has been far less studied. Follow-up or treatment studies of this disorder are even scarcer.
  • #33 Somatic symptom disorder: Epidemiology, clinical features, and course of illness – UpToDate
    https://www.uptodate.com/contents/somatic-symptom-disorder-epidemiology-and-clinical-presentation
    Somatic symptom disorder: Epidemiology, clinical features, and course of illness […] This topic reviews the epidemiology, pathogenesis, clinical features, and course of illness in somatic symptom disorder. […] Somatic symptom disorder is a diagnosis that was introduced in 2013. […] Most of the patients who were previously diagnosed with somatoform disorders are now diagnosed in DSM-5-TR with somatic symptom disorder.
  • #34 Somatic Symptom Disorder Statistics | Learn about Its Prevalence and Treatment
    https://www.therecoveryvillage.com/mental-health/somatic-symptom-disorder/ssd-statistics/
    Somatic symptom disorders are relatively common, affecting about 57% of the population of the United States. It can affect children, teenagers and adults. Its prevalence is far higher in women than in men, and the female to male ratio of patients is about 10:1. […] Since the definition of somatic symptom disorder has changed recently, research on the condition is still limited. However, the latest statistics show it may be more common than one might think. Greater awareness is essential for people with the disease to find the help they need.
  • #35
    https://link.springer.com/article/10.1007/BF00800664
    Since the exclusion of somatic causes is necessary for somatoform disorders (SMD) to be diagnosed, there is little information on the prevalence of such disorders in the community. […] The prevalence rates of DSM-III-R somatoform disorders were studied in two wards of the city of Florence. […] The 1-year prevalence figures were as follows: 0.7% body dysmorphic disorder; 4.5% hypochondriasis; 0.6% somatoform pain disorder; 0.3% conversion disorder; 0.7% somatization disorder; 13.8% undifferentiated somatoform disorder. […] Although the sample investigated was small, this study may be seen as one of the first in an area where knowledge is still scant. The prevalence rates of somatoform disorders were generally found to be slightly lower than expected.
  • #36 Somatic symptom and related disorders – Knowledge @ AMBOSS
    https://www.amboss.com/us/knowledge/somatic-symptom-and-related-disorders/
    Prevalence in adults: 57% […] Screening tools may identify patients at risk for somatic symptom disorder. […] Patients with somatic symptom disorder often visit multiple physicians.
  • #37
    https://journals.lww.com/10.1097/PSY.0000000000000530
    The new DSM-5 somatic symptom disorder was introduced to improve the diagnosis of persons experiencing what used to be called somatoform disorders. […] A nationally representative general population survey was performed resulting in 250 participants (minimum age = 14 years. 12.8% participation rate). […] Diagnostic accuracy was adequate to good for each individual questionnaire (PHQ-15: AUC = 0.79, p .001, 95% confidence interval [CI] = 0.730.85; WI-7: AUC = 0.76, p .001, 95% CI = 0.690.83; SAIB: AUC = 0.77, p .001, 95% CI = 0.710.83). […] The PHQ-15, WI-7, and SAIB are useful screening instruments to detect persons at risk for somatic symptom disorder, and a combination of these three instruments slightly improves diagnostic accuracy. Their use in routine care will lead to improved detection rates.
  • #38 Somatization in childhood and adolescence: a guide to facilitate its understanding | Anales de Pediatría
    https://www.analesdepediatria.org/en-somatization-in-childhood-adolescence-guide-articulo-S2341287925000237
    Somatic symptoms affect approximately 25% of children and adolescents, with a significant impact in 10%, and somatization disorders affect 1%3% of the population. […] The estimated prevalence of somatic symptom disorders is approximately one to three percent. […] These complaints usually affect the patients quality of life, family and social adaptation, cognitive development, academic performance and mood. […] Overall, there is a higher prevalence of these disorders in the female population, and the age at onset is greater in conversion disorder compared to somatic symptom disorder. […] Somatic symptoms are very frequent in children and adolescents, and somatoform disorders occur in 1%2% of the pediatric population.
  • #39 Prevalence and characteristics of somatic symptom disorder in the elderly in a community-based population: a large-scale cross-sectional study in China | BMC Psychiatry | Full Text
    https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-022-03907-1
    SSD screening should be given more attention in the elderly, especially among older females with several comorbid physical diseases. […] This study reveals that the prevalence of SSD in the elderly in China is higher than that in non-elderly populations, and SSD severity tends to worsen with age. […] Finally, we found that female sex and the existence of physical diseases are associated with higher SSD prevalence.
  • #40
    https://journals.lww.com/iopn/fulltext/2013/05010/epidemiology_and_co_morbidity_of_somatoform.12.aspx
    A high co-morbidity of somatoform disorders and anxiety or depressive disorders has been a common finding in several studies. […] Patients with hypochondriasis view their health as poor and have greater impairment in physical functioning and work performance than patients with comparable physical disease. […] There is a need for further intense research to be carried out using population based samples and patients coming for consultation to primary care centers.
  • #41 Prevalence of Somatic Symptoms and Somatoform Disorders among a German Adolescent Psychiatric Inpatient Sample
    https://www.mdpi.com/2227-9067/11/3/280
    We hypothesized to find substantial portions of somatic symptoms in this clinical cohort even when no SD diagnosis was given. […] We further hypothesized that somatic symptoms would be correlated with symptoms of anxiety and depression and account for impairment in everyday functioning together with depression and anxiety. […] In our study, we found a high prevalence of somatic symptoms in adolescent psychiatric inpatients, as the majority of the adolescents reported at least one unexplained somatic symptom within the past six months and almost half of our cohort had at least one symptom during the last seven days prior to the survey. […] We also found somatic symptoms to be highly correlated with symptoms of depression and particularly anxiety but, using linear regressions, only the number of somatic symptoms explained everyday impairment in patients with comorbid anxiety and depressive symptoms. […] Our data suggest that somatic symptoms in child and adolescent psychiatric patients are so frequent that—starting at the age of 11 and especially in patients with internalizing symptoms—screening for somatic symptoms and SD should be integrated in routine diagnostic procedures.